(Q40707869)

22 September 2017

title

Phase I study of combined alpha interferon, alpha difluoromethylornithine (DFMO), and doxorubicin in advanced malignancy (English)

1 reference

22 September 2017

1 reference

V Ganju

1

1 reference

22 September 2017

J H Edmonson

series ordinal

2

1 reference

22 September 2017

J C Buckner

series ordinal

3

1 reference

22 September 2017

publication date

1 January 1994

1 reference

Investigational New Drugs

22 September 2017

published in

1 reference

22 September 2017

volume

12

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

25-27

1 reference

Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease

22 September 2017

cites work

1 reference

12 December 2020

Polyamine metabolism and function

1 reference

12 December 2020

Effects of alpha-difluoromethylornithine and 5-fluorouracil on the proliferation of a human colon adenocarcinoma cell line

1 reference

12 December 2020

Phase II assessment of recombinant leukocyte A interferon with difluoromethylornithine in disseminated malignant melanoma

1 reference

12 December 2020

In vitro data supporting interferon plus cytotoxic agent combinations.

1 reference

12 December 2020

Decreased cytotoxicity of 1-beta-D-arabinofuranosylcytosine in 9L rat brain tumor cells pretreated with alpha-difluoromethylornithine in vitro

1 reference

12 December 2020

Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.

1 reference

12 December 2020

Inhibition of polyamine biosynthesis by alpha-difluoromethyl ornithine potentiates the cytotoxic effects of arabinosyl cytosine in HeLa cells

1 reference

12 December 2020

Anti-proliferative properties of DL-alpha-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase

1 reference

12 December 2020

Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon.

1 reference

12 December 2020

Ornithine decarboxylase: essential in proliferation but not differentiation of human promyelocytic leukemia cells

1 reference

12 December 2020

Polyamines are necessary for the survival of human small-cell lung carcinoma in culture

1 reference

12 December 2020

Alpha interferon for induction of remission in hairy-cell leukemia

1 reference

12 December 2020

Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.

1 reference

12 December 2020

Tumor Suppression with a Combination of α-Difluoromethyl Ornithine and Interferon

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00873231

1 reference

Dimensions Publication ID

22 September 2017

1032921959

0 references

1 reference